Follow-up Study 16-20 Years After Primary Vaccination Against Hepatitis B of Newborns From HBeAg+ & HBsAg+ Mothers
Clinical trial NCT00240500 · COMPLETED
Trial details
- NCT number
- NCT00240500
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2003-10-01
- Primary completion
- 2007-11-01
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.